Barrick Gold Major Multi Year Support Holding

Barrick Gold has been one of the hardest hit large cap gold producers.  It has filled the headlines with huge write downs and corporate mismanagement.  It has found support that reaches all the way back to 1992.  I think these levels will hold.  A fast move back to $30 would not be surprising.

Big Pharma And Health Care Stocks Enter Year II Of Secular Bull Market

After a long, dark 10+ year secular bear market for mega cap drug companies plagued with expiring patents on blockbuster medications, a new secular bull market has now emerged.  We are currently in year II of the massive uptrend if you consider that XLV posted new multi-year highs in 2012.  JNJ is the ultimate bellwether for the health care sector and is also well on its way to higher highs.  Other mega cap drug companies (PFE, MRK and BMY) are nearing their old 2000 era highs now.  They will likely pause before smashing through these levels in the coming months (but one can never be too sure).  The biotechnology companies are leading the entire health care sector and will likely dominate the industry in the years to come.

IBB vs. FBT Extreme Biotechnology ETFs

If you can stomach extreme volatility (ie. a near 50% correction like in 2011), FBT by First Trust is the ultra biotechnology ETF.  They're also the creators of FDN, the Dow Jones Internet Index ETF which is also on fire (it's 10% GOOG).

PerfCharts Are A Great Tool For Identifying Market Leading And Lagging Sectors

Great video tutorial found at stockcharts.com.

http://stockcharts.com/videos/?fv=usvs-ah-newperfcharts-p1

PerfChart tool link at stockcharts.com:

http://stockcharts.com/freecharts/perf.php?[SECT]

IBD Internet Price & Volume Screen

All of these stocks have nice charts.

Large Triangle Patterns Are Extremely Bullish

The larger and tighter the triangle, the more bullish the pattern of price consolidation.  YHOO has broken out, AKAM is getting very close.

Biotechnology Mega Cap Stocks 5 Year Chart Comparison

Biotechnology is leading the way forward for the NASDAQ.  AMGN, CELG and GILD are the biotech mega cap leaders.